First AI-designed ‘universal vaccine’ tested in humans

Researchers at the University of Cambridge have conducted the first human trial of a vaccine with an active ingredient entirely designed by artificial intelligence. The experimental jab aims to provide universal protection against a broad range of viruses, including those that cause Covid-19, Sars, and Mers.
Why it matters
This marks a significant milestone in medical science, potentially shifting vaccine development from a reactive process to a proactive, future-proof model.
The experimental jab is intended to target a wide range of viruses, including those behind deadly outbreaks like Sars, Mers and Covid-19
The article reports on scientific findings using neutral, factual language without political or ideological framing.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in